It all started with a vision: to develop and produce innovative in vitro diagnostic products, primarily for tumour diagnosis, based on the technique of in situ hybridization. That vision has since become reality, with the result that the name »ZytoVision« is identified the world over with technological and cost leadership in this field.
Our company – a privately managed enterprise based in Bremerhaven, Germany – has been operating successfully in the international market for more than 10 years and is widely regarded as a pioneer in high-quality diagnostic devices. More than 50 employees are working continuously to develop, improve, produce and package our products. And we are steadfast in our goal of ensuring that our product portfolio is always complete and up-to-date in our core areas of solid and haematological tumour diagnostics. Our more than 250 CE-certified IVDs (in vitro diagnostic devices) are already being used in more than 60 countries around the world.